Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. - Lindholm,LH.; Ibsen,H.; Dahlof,B.; Devereux,RB.; Beevers,G.; Faire,U De.; Fyhrquist,F.; Julius,S.; Kjeldsen,SE.; Kristiansson,K.; Lederballe-Pedersen,O.; Nieminen,MS.; et al. (Lancet, 2002)